Press Releases

  • Genetics of rapid antler growth

    Stanford scientists and their collaborators have identified two key genes responsible for the rapid growth of deer antlers. They hope their insights will open the door to new approaches for treating bone diseases and fractures.

  • Clue charting cancer gene regulation

    Understanding when and where proteins bind to DNA may be the ticket to identifying cancer at the cellular level, according to researchers at Stanford.

  • Adult stem cells channel early development

    New research from Stanford shows that skeletal stem cells in mice assume a more primitive developmental state in response to extensive regeneration needs and environmental cues.

  • Juul e-cigarettes pose risks to youth

    Teens are struggling to recognize the addictive potential of Juul e-cigarettes, a product that appeals to youth, according to a team of Stanford researchers.

  • Ketoprofen treats symptoms of lymphedema

    Two early-stage clinical trials led by Stanford researchers have shown that ketoprofen can improve skin damage in patients with lymphedema.

  • Concussion study in high school football

    Three Bay Area high school football teams have been outfitted with mouthguards that measure head motion. Stanford scientists hope to use the data to better understand what causes concussions.

  • Bloodstream pathogens often come from gut

    A computational tool designed by Stanford scientists makes it easier to identify the source of bloodstream infections and, ideally, rid patients of reservoirs where potentially troublesome microbes reside.

  • Rearranging genome with CRISPR

    Using a new variation of gene-editing technology CRISPR, Stanford scientists were able to change the spatial organization of DNA in cell nuclei and show how physical relocation altered cell function.

  • Undiagnosed patients get answers

    A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases, according to a new study.

  • Mutations point to possible drug targets

    Genetic data from nearly 300,000 patients has helped scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, according to a new study.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.